Marvel Biosciences Announces Positive Interim Results on Tau Phosphorylation with MB-204 : vimarsana.com

Marvel Biosciences Corp. , and its wholly owned subsidiary, Marvel Biotechnology Inc. , today reported promising interim results from its acute study on MB-204 conducted by Professor Emmanuel Planel...

Related Keywords

Mark Williams , Emmanuel Planel , Marvel Biotechnology Inc , Regulation Services Provider , Alberta Newsfile Corp , Laval University , Marvel Biosciences Corp , Venture Exchange , Company Or Marvel , Marvel Biotechnology , Professor Emmanuel Planel , Abnormal Tau , Chronic Traumatic Encephalopathy , Biosciences Corp , Chief Executive Officer , Chief Science , Markets ,